US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Abstract The report covers forecast and analysis for the bovine ephemeral fever vaccines market on a global and regional level. The study provides historic data from 2015 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the bovine ephemeral fever vaccines market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities and various trends in the bovine ephemeral fever vaccines market on a global level. As per the report, the global demand for bovine ephemeral fever vaccines market was valued at approximately USD 64.8 Million in 2018 and is expected to generate revenue of around USD 78.9 Million by end of 2025, growing at a CAGR of around 2.81% between 2019 and 2025. Worldwide demand for bovine ephemeral fever vaccines is growing at a rapid pace. Global demand for bovine ephemeral fever vaccines is expected to be driven by increasing demand from pharmaceutical companies, large number of companies providing healthcare services and vaccines, a large number of biopharmaceutical companies producing vaccines, and a high incidence of bovine ephemeral fever (BEF) among cattle and buffaloes. The increase in R&D in the field of vaccines is expected to be the major factor attributing to the growth of bovine ephemeral fever vaccines market. However, the practical difficulties in the administration of the vaccine and the lack of trained veterinarian professionals may act as a restraint for bovine ephemeral fever vaccines market growth. Emerging countries are expected to bring new growth avenues for bovine ephemeral fever vaccines manufacturers. Based on type, the market is segmented into type, application, end user, and region. Among the type segment, there are live vaccines, killed vaccines, and other types. Applications include vaccines administered among cattle and water buffaloes. A large number of cattle and water buffaloes in the sub-tropical regions of Asia, Australia, Africa, and the Middle-East are affected by this disease. Live-attenuated vaccines held the largest market share in 2018. This has been observed by testing and demonstrating results in various affected cattle. The duration of immunity conferred by these vaccines is high. medical device companies, pharmaceutical industries, and animal hospitals are the various end users in this market. Animal hospitals are the major end user segment which dominated the market in terms of revenue in 2018 owing to a large number of diseased cattle that are treated and the intensive care that is provided in such establishments. North America dominated global bovine ephemeral fever vaccines market. North America region is projected to lead the market over the forecast period with progress mostly focused in the U.S. market. There are a large number of companies which are heavily investing in research and development of vaccines for animal health care. There are a growing number of biopharmaceutical companies in the market which are developing vaccines for animal care and prevention of diseases. Europe was second largest in bovine ephemeral fever vaccines market in 2018 globally. The spike of R&D in the field of animal and human health care, large number of companies manufacturing vaccines and advanced technologies is the major factor driving the demand for bovine ephemeral fever vaccines in Europe. Asia Pacific, the Middle East and Africa are having high prevalence of BEFV infection. This is due to the sub-tropical temperatures which result in anorexia, lameness, ruminal stasis, fever and a reduction in production of milk. However, to tackle this onslaught of vector-borne diseases, there is regular vaccination carried out, resulting in a growth of CAGR over the forecast period. There is also improved awareness among people to take care of the animals and growing demand for biotechnological companies to produce related vaccines. Some of the key players in bovine ephemeral fever vaccines market include Zoetis Inc., Onderstepoort Biological Products SOC Ltd., Green Cross Veterinary Products Co. Ltd., Veterinary Serum & Vaccine Research Institute and CAVAC (ChoongAng Vaccine Laboratories Co. Ltd. among others. Global Bovine Ephemeral Fever Vaccines Market: Type Segment Analysis live vaccine killed vaccine others Global Bovine Ephemeral Fever Vaccines Market: Application Segment Analysis cattle water buffaloes Global Bovine Ephemeral Fever Vaccines Market: End-User Segment Analysis Medical Device Companies Pharmaceutical industries Animal hospitals Other End Users Global Bovine Ephemeral Fever Vaccines Market: Regional Segment Analysis North America U.S. Europe UK France Germany Asia Pacific China Japan India Latin America Brazil Middle East and Africa
Table of Contents Request Table Of Content Click To Request Sample | read more...